PANCREAZE (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the PANCREAZE drug offered from Janssen Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | PANCRELIPASE |
| SUBSTANCE NAME: | PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-04-12 |
| END MARKETING DATE: | 0000-00-00 |
PANCREAZE HUMAN PRESCRIPTION DRUG Details:
| Item Description | PANCREAZE from Janssen Pharmaceuticals, Inc. |
| LABELER NAME: | Janssen Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4200; 24600; 14200([USP’U]/1; [USP’U]/1; [USP’U]/1) |
| START MARKETING DATE: | 2010-04-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50458-341_c9e43d34-a442-4db8-82b8-636f9ca562a2 |
| PRODUCT NDC: | 50458-341 |
| APPLICATION NUMBER: | NDA022523 |
Other PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE Pharmaceutical Manufacturers / Labelers:
